SinuSys
Three new appointments now from sinusitis therapy and technology developers SinuSys:
- Michael Daniel (left) will serve as acting Vice President, Regulatory
- Eric Schaefer (middle)as Director, Commercial Development
- Sagar Pushpala (right) as Operations Advisor
Thomas Schreck, CEO of SinuSys said of the new appointees: “Their respective expertise in regulatory affairs, commercialization, and technology operations management will further ensure our success as we expand internationally, scale up manufacturing, and prepare for entry into the US market.”